To determine if increased NF-κB activity was associated with poor survival outcomes in ccRCC, we examined the correlation between expression of genes in our NF-κB signature and overall survival for 55 ccRCC patients whose gene expression and survival data were available in The Cancer Genome Atlas (TCGA). This evidence concerns the gene NFKB1 and nonpapillary renal cell carcinoma.